Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Open-Label, Single Arm, Non-Controlled, Single-Stage Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Plexiform Neurofibroma and Neurofibromatosis Type 1

NCT06541847 is registered in ClinicalTrials.gov with Healx Limited as lead sponsor.

NCT NCT06541847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06541847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Open-Label, Single Arm, Non-Controlled, Single-Stage Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Plexiform Neurofibroma and Neurofibromatosis Type 1
Lead sponsor
Healx Limited
Phase
Phase 2
Overall status
Recruiting
Start date
February 10, 2025
Completion date
January 31, 2028
Enrollment
25 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis type 1